New Brunswick, NJ (October 25, 2012) – Johnson & Johnson (NYSE: JNJ) will host a Medical Devices & Diagnostics business review for the investment community beginning at 8:30 a.m. (Eastern Time) on Thursday, November 1st at the Hyatt Regency Hotel in New Brunswick, N.J.
The program will include presentations by Johnson & Johnson’s senior management representing our Medical Devices & Diagnostics segments. Dominic Caruso, Vice President, Finance and Chief Financial Officer will open the meeting.
A live webcast will be available through www.investor.jnj.com. This webcast is optimized for mobile streaming on iOS devices such as iPhones, iPods, and iPads. A replay and podcast will be available approximately two hours after the meeting concludes.
# # #
Press Contacts:
Al Wasilewski
(732) 524-1130
Bill Price
(732) 524-6623
Investor Contacts:
Louise Mehrotra
(732) 524-6491
Stan Panasewicz
(732) 524-2524
Lesley Fishman
(732) 524-3922
Ellen Sipos
(732) 524-3709
New Brunswick, NJ (October 25, 2012) – Johnson & Johnson (NYSE: JNJ) will host a Medical Devices & Diagnostics business review for the investment community beginning at 8:30 a.m. (Eastern Time) on Thursday, November 1st at the Hyatt Regency Hotel in New Brunswick, N.J.
The program will include presentations by Johnson & Johnson’s senior management representing our Medical Devices & Diagnostics segments. Dominic Caruso, Vice President, Finance and Chief Financial Officer will open the meeting.
A live webcast will be available through www.investor.jnj.com. This webcast is optimized for mobile streaming on iOS devices such as iPhones, iPods, and iPads. A replay and podcast will be available approximately two hours after the meeting concludes.
# # #
Press Contacts:
Al Wasilewski
(732) 524-1130
Bill Price
(732) 524-6623
Investor Contacts:
Louise Mehrotra
(732) 524-6491
Stan Panasewicz
(732) 524-2524
Lesley Fishman
(732) 524-3922
Ellen Sipos
(732) 524-3709